Sort
17,828 grants matching “crispr”
How do nucleation promoting factors build different actin networks?
$36,958Rachel Marie Brunetti · University Of California, San Francisco · F31 · FY2019 · HL
Investigating the Role of Transcription on DNA Damage at Early Replicating Fragile Sites
$36,958Commodore Perry St Germain · University Of California At Davis · F31 · FY2019 · CA
Human CRISPRa Cardiac Reprogramming: Model Characterization and Epigenetic Mechanisms
$36,939Benjamin Keepers · Univ Of North Carolina Chapel Hill · F30 · FY2020 · HL
Identification of Molecular Mechanisms Underlying Early Atherosclerosis
$36,936Genesio Karere · Wake Forest University Health Sciences · K01 · FY2021 · HL
Effects of Ventral Tegmental Area Dopamine Neurons GABA-B Receptor Deletion on Cue-Evoked Relapse and Aversion-Resistant Drinking
$36,914Jonathan Israel Aguirre · University Of Minnesota · F31 · FY2025 · AA
Genetic Strategies for the Treatment of Usher Syndrome in Mice
$36,869Katelyn N Robillard · Lsu Health Sciences Center · F30 · FY2019 · EY
Regulation and function of CCR2 on T cells in Rheumatoid Arthritis
$36,856Sabrina Esmeralda Bracero · Harvard Medical School · F31 · FY2024 · AR
The role of SLC11A1 in neutrophil antimicrobial response
$36,847Annica Stull-Lane · University Of California At Davis · F30 · FY2023 · AI
The Role of microRNAs in BRAFV600E-driven Nevus Growth Arrest
$36,812Andrew McNeal · University Of California, San Francisco · F31 · FY2019 · CA
Systematic Characterization of Tauopathy-Associated Genetic Variation using Multiplexed Reporter Assays
$36,788Yonatan Cooper · University Of California Los Angeles · F30 · FY2019 · AG
Elucidating cellular pathways controlling the reactive state of astrocytes in Alzheimerâs Disease
$36,779Kun Leng · University Of California, San Francisco · F30 · FY2019 · AG
Shared Resource: Transgenic Mouse Facility
$36,762Dietmar J Kappes · Research Inst Of Fox Chase Can Ctr · P30 · FY2021 · CA
Interrogating the role for ATP-dependent chromatin remodeling complexes in immune response
$36,757Dawn E Comstock · Harvard Medical School · F30 · FY2020 · CA
Mitochondrial quality control as a selective vulnerability in cancers with chromosome 10q deletion
$36,735Jacob Michael Winter · University Of Utah · F30 · FY2021 · CA
Understanding the role of PRDM1 in limb development and split hand/foot malformation.
$36,720Brittany Truong · University Of Colorado Denver · F31 · FY2020 · HD
Isolating Ventricular Progenitor Cells with an Irx4 Reporter, Nanoflares, and Domain Antibodies
$36,705Mitch Biermann · University Of Wisconsin-Madison · F30 · FY2017 · HL
Enhancing Safety and Efficacy of Stem-Cell Derived Islet Transplantation using CRISPR-Mediated Genome Engineering
$36,700Simon Chu · University Of California, San Francisco · F32 · FY2024 · DK
Ionizable Lipid Nanoparticles for Fetal Lung Targeting
$36,681Rohan Palanki · University Of Pennsylvania · F30 · FY2024 · HL
New Genetic Tools for Accessing Anti-Infective Agents from Gram-Negative Bacteria
$36,680Jamie Zhang · University Of California, San Diego · F31 · FY2017 · AI
Mechanisms of MHC-deficient tumor clearance using STING agonists
$36,670Christopher James Nicolai · University Of California Berkeley · F31 · FY2019 · CA
Identifying the Role of Tumor Cell Intrinsic DNMT1 in Anti-Tumor Immunity in Pancreatic Ductal Adenocarcinoma
$36,670Erin Elizabeth Hollander · University Of Pennsylvania · F30 · FY2024 · CA
Investigating SNX13 in Cerebellar Function and Disease
$36,651Vanessa Breanne Sanchez · University Of Pennsylvania · F31 · FY2024 · NS
Investigating molecular mechanism of immune response during cancer progression
$36,633Zeyu Chen · Dana-Farber Cancer Inst · K00 · FY2021 · CA
Characterization and engineering of a compact genome editor for adeno-associated virus delivery to correct mutations causing cystic fibrosis
$36,602Connor Andrew Tsuchida · University Of California Berkeley · F31 · FY2022 · HL
Improving targeted nuclease-mediated gene correction in human hematopoietic stem cells
$36,588Anastasia Lomova · University Of California Los Angeles · F31 · FY2018 · HL